SK Discovery

006120 · KOSPI · Financials · SMALL CAP

A new supply contract.

SK Discovery disclosed a subsidiary's supply contract with A.K.S.I.A HEALTH CARE FZC., worth US$12.2M, about 8.39% of the subsidiary's recent annual revenue, running through Dec 2029.

Supply contract(Supply contract signed (subsidiary))· FILED 2026-04-03· RCEPT 20260403801446

US$12.2MContract value
8.39%vs. subsidiary revenue
Dec 2029Throughfrom Apr 2026

Converted at 1 USD ≈ ₩1,509.22 (filing-date rate, 2026-04-02 close)

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-08-28) →

What happened

SK Discovery disclosed a subsidiary's supply contract with A.K.S.I.A HEALTH CARE FZC., worth US$12.2M, about 8.39% of the subsidiary's recent annual revenue, running through Dec 2029.

For context, this single contract equals about 8.39% of the subsidiary's most recent annual revenue.

CounterpartyA.K.S.I.A HEALTH CARE FZC.
Contract valueUS$12.2M
vs. subsidiary revenue8.39%
ThroughDec 2029 (from Apr 2026)
Filed2026-04-03, Supply contract signed (subsidiary)
SourceDART rcept 20260403801446 → open original filing

Versions of this filing

  1. 2026-04-03Original (this page)
  2. 2026-08-28Amendment 1

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-04-03 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.